OEM/ODM Supplier Cas No.112516-05-9 - Neoliquiritin – Yongjian
OEM/ODM Supplier Cas No.112516-05-9 - Neoliquiritin – Yongjian Detail:
Application of Neoliquiritin
Neoliquitin is isolated from Glycyrrhiza uralensis and has anti-inflammatory activity.
Name of Neoliquiritin
Chinese name: Neoglycyrrhizin
English Name: neoliquitin
Chinese alias: glycyrrhizin 7-beta-d-glucopyranoside
Bioactivity of Neoliquiritin
Description: neoliquitin is isolated from Glycyrrhiza uralensis and has anti-inflammatory activity.
Related Categories: Signal path > > other > > other
Reference: [1]. Wang J, et al. Assessment of genetic fidelity and composition: Mixed elicitors enhance triterpenoid and flavonoid biosynthesis of Glycyrrhiza uralensis Fisch. tissue cultures. Biotechnol Appl Biochem. 2017 Mar;64(2):211-217.
Physicochemical Properties of Neoliquiritin
Density: 1.5 ± 0.1 g / cm3
Boiling Point: 746.8 ± 60.0 ° C at 760 mmHg
Molecular Formula: c21h22o9
Molecular Weight: 418.394
Flash Point: 265.9 ± 26.4 ° C
Exact Mass: 418.126373
LogP:0.61
Steam Pressure: 0.0 ± 2.6 mmHg at 25 ° C
Refractive Index: 1.670
English Alias of Neoliquiritin
Liquiritoside
4H-1-Benzopyran-4-one, 2-(4-(β-D-glucopyranosyloxy)phenyl)-2,3-dihydro-7-hydroxy-, (S)-
4′,7-Dihydroxyflavanone 4′-(β-D-glucoside)
(S) -2-(4-(β-D-Glucopyranosyloxy)phenyl)-2,3-dihydro-7-hydroxy-4H-1-benzopyran-4-one
4H-1-Benzopyran-4-one, 2-[4-(β-D-glucopyranosyloxy)phenyl]-2,3-dihydro-7-hydroxy-, (2S)-
4′,7-Dihydroxyflavanone 4′-(β-D-glucopyranoside)
Liquiritigenin 7-beta-D-glucopyranoside
4-[(2S)-7-Hydroxy-4-oxo-3,4-dihydro-2H-chromen-2-yl]phenyl β-D-glucopyranoside
Liquiritin
Liquiritigenin-4′-O-glucoside
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd.
Established in March 2012, Jiangsu Yongjian Pharmaceutical Technology Co., Ltd. is a production and sales enterprise integrating high-tech. It is mainly engaged in the production, customization and production process development of active components of natural products, traditional Chinese medicine reference materials and drug impurities. The company is located in China Pharmaceutical City, Taizhou City, Jiangsu Province, including a 5000 square meter production base and a 2000 square meter R & D base. It mainly serves major scientific research institutes, universities and decoction piece production enterprises across the country.
So far, we have developed more than 1500 kinds of natural compound reagents, and compared and calibrated more than 300 kinds of reference materials, which can fully meet the daily inspection needs of major scientific research institutes, university laboratories and decoction pieces production enterprises.
Based on the principle of good faith, the company hopes to sincerely cooperate with our customers. Our aim is to serve the modernization of traditional Chinese medicine.
Advantageous Business Scope Of The company
1. R & D, production and sales of chemical reference materials of traditional Chinese medicine;
2. Customized traditional Chinese medicine monomer compounds according to customer characteristics
3. Research on quality standard and process development of traditional Chinese medicine (plant) extract
4. Technology cooperation, transfer and new drug research and development.
Product detail pictures:
Related Product Guide:
While using the "Client-Oriented" company philosophy, a demanding high-quality management method, innovative producing products and also a sturdy R&D workforce, we always deliver premium quality merchandise, superb solutions and aggressive selling prices for OEM/ODM Supplier Cas No.112516-05-9 - Neoliquiritin – Yongjian , The product will supply to all over the world, such as: Burundi, Philippines, Peru, With the spirit of "credit first, development through innovation, sincere cooperation and joint growth", our company is striving to create a brilliant future with you, so as to become a most valuable platform for exporting our goods in China!
By Mike from Indonesia - 2017.09.16 13:44
The company comply with the contract strict, a very reputable manufacturers, worthy a long-term cooperation.
By Emily from Dubai - 2018.09.29 13:24